Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human...

Area of Science:

• Immunology
• Dermatology
• Molecular Biology
• Genomics

Background:

• The molecular underpinnings of skin fibrosis in murine sclerodermatous graft-versus-host disease (Scl GVHD) remain largely unknown.
• Understanding these mechanisms is crucial for developing effective treatments for Scl GVHD and human scleroderma.

Purpose of the Study:

• To characterize global gene expression in the skin during the development of Scl GVHD in a murine model.
• To identify key molecular pathways and potential biomarkers associated with fibrotic skin disease.

Main Methods:

• Utilized Affymetrix DNA microarrays to analyze gene expression (>14,000 genes) in the skin of mice with induced Scl GVHD.
• Compared gene expression profiles between Scl GVHD mice and control groups receiving syngeneic transplants.
• Confirmed protein synthesis of specific cytokines (IFN-gamma, IL-2, IL-10, TNF-alpha, IL-4) using flow cytometry.

Main Results:

• Identified significant differences in messenger RNA (mRNA) levels for Th1-like (IFN-gamma) and Th2-like (IL-6, IL-10, IL-13) cytokines.
• Observed elevated mRNAs for various chemokines (CCL2, CCL5, CCL17, CXCL9, CXCL10, CXCL11) and growth factors (PDGF-c, CTGF, FGF1, EGF, NGF-beta, VEGF-alpha, VEGF-beta).
• Found upregulation of cell adhesion molecule mRNAs (L-selectin, P-selectin, E-selectin, VCAM1), mirroring patterns seen in human scleroderma.

Conclusions:

• The identified gene expression patterns provide a molecular 'fingerprint' for fibrosing autoimmune diseases like Scl GVHD.
• These findings enhance understanding of Scl GVHD pathogenesis and suggest potential targets for early diagnosis and therapeutic intervention.
• The study highlights similarities between murine Scl GVHD and human scleroderma, validating the model for further research.